NATALIZUMAB

UNII:	3JB47N2Q2P
Formula:
Preferred Substance Name:	NATALIZUMAB

189261-10-7
AN100226M
ANTEGRAN
ANTEGREN
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
NATALIZUMAB [EMA EPAR]
NATALIZUMAB [INN]
NATALIZUMAB [JAN]
NATALIZUMAB [MART.]
NATALIZUMAB [MI]
NATALIZUMAB [PURPLE BOOK CDER]
NATALIZUMAB [USAN]
NATALIZUMAB [VANDF]
NATALIZUMAB [WHO-DD]
NATALIZUMAB ELAN PHARMA
TYSABRI

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NATALIZUMAB

Synonyms and Mappings

Resources